FindTrial
Sign In

Effects of drug Lignocaine with drug Dexmedetomidine as Nebulisation for awake intubation through nose by using video endoscope

Comparative Evaluation Of Lignocaine Nebulisation With And Without Dexmedetomidine As Premedication For Flexible Videoendoscopic Guided Awake Nasal Intubation In General Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018607
Enrollment
96
Registered
2019-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Lignocaine Nebulisation with and without Dexmedetomidine: To Study Evaluation of Lignocaine Nebulisation with and without Dexmedetomidine as premedication for flexible videoendoscopic g

Sponsors

Maharana Bhupal Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II Aged 15 to 65 Including either gender, scheduled for elective surgeries under general anesthesia

Exclusion criteria

Exclusion criteria: Baseline heart rate less than 60 per minute Baseline blood pressure less than 100/50 mm of Hg Allergic reactions to drugs History of Hypertension and cardia diseases Requiring 2 more attempts for videoendoscopic intubation and use of more sedation will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Pre anesthetic examination, thorough airway examination. vital parameters like BP, pulse, temperature and respiratory rate, sedation effectsTimepoint: from the start of Nebulisation until 15 minutes post intubation—

Secondary

MeasureTime frame
noneTimepoint: none—

Countries

India

Contacts

Public ContactJyoti Gaikwad

RNT Medical College, Udaipur

khemraj10@gmail.com9414759782

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026